Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV
For HIV-infected children, formulation development, pharmacokinetic (PK) data, and evaluation of early toxicity are critical for licensing new antiretroviral drugs; direct evidence of efficacy in children may not be needed if acceptable safety and PK parameters are demonstrated in children. However,...
Saved in:
Main Authors: | Deborah Ford, Rebecca Turner, Anna Turkova, Martina Penazzato, Victor Musiime, Mutsa Bwakura-Dangarembizi, Avy Violari, Chishala Chabala, Thanyawee Puthanakit, Tavitiya Sudjaritruk, Tim R. Cressey, Marc Lallemant, Diana M. Gibb |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85055149780&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/62807 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Optimizing Pediatric Dosing Recommendations and Treatment Management of Antiretroviral Drugs Using Therapeutic Drug Monitoring Data in Children Living With HIV
by: Hylke Waalewijn, et al.
Published: (2019) -
Plasma efavirenz concentrations and the association with CYP2B6-516G>T polymorphism in HIV-infected Thai Children
by: Thanyawee Puthanakit, et al.
Published: (2018) -
Plasma efavirenz concentrations and the association with CYP2B6-516G>T polymorphism in HIV-infected Thai Children
by: Thanyawee Puthanakit, et al.
Published: (2018) -
Pharmacogenetics and the prevention of mother-to-child transmission of HIV
by: Tim R. Cressey, et al.
Published: (2018) -
The 10-year effectiveness of combination antiretroviral treatment in perinatally HIV-infected children participating in Thailand's National Access Program
by: Linda Aurpibul, et al.
Published: (2018)